Healthcare IT Today November 6, 2020
The following is a guest article by Haim Neerman, CEO at Variantyx.
As a society, how much should be invested in creating a “transformative textbook of medicine, with insights that will give health care providers immense new power to treat, prevent and cure disease”?
In this case, it is a trick question. The investment has already been made. Thirteen years and billions of dollars later the apt description of the return on investment you just read was provided in 2001 by Francis Collins, then director of the National Human Genome Research Institute. The Human Genome Project has also been described it as “one of the great feats of exploration in history” which “gave us the ability, for the first time,...